EMA
approval
· 2026-02-20
EMA Authorised: Palonosetron Accord (palonosetron) — Accord Healthcare S.L.U.
Summary
The EMA authorised Palonosetron Accord (palonosetron) from Accord Healthcare S.L.U. for the prevention of nausea and vomiting in cancer patients, including chem…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Vomiting;Nausea;Cancer. MAH: Accord Healthcare S.L.U.. Decision date: 18/02/2026